Do the six RCTs in the meta-regression give any signal on which patient phenotype holds onto that residual loss, or is the data too heterogeneous to split out yet
the manuscript, figures, and tables have not been published and are not being considered for publication elsewhere, except for abstracts presented to the American Heart Association Hypertension conference in the 20182021 Scientific Sessions
Kartolo, A., Sattar, J., Sahai, V., Baetz, T
Because this study reflects real-world prescribing patterns, medication use outside the controlled trial environment, and outcomes across diverse clinical settings, it provides practical evidence that can inform daily decision-making